124
Participants
Start Date
October 29, 2020
Primary Completion Date
August 9, 2023
Study Completion Date
August 9, 2023
MT-1186
Treatment cycles with daily dosing for 10 days out of a 14-day period, followed by a 14 day drug free period up to 96 weeks of treatment or until the drug is commercially available in that country.
Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA), Turin
Alleghany General Hospital, Pittsburgh
Penn State Hershey Children's Hospital, Hershey
Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele), Milan
Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre), Milan
Johns Hopkins University, Baltimore
Wake Forest University Baptist Medical Center (WFUBMC) - The J. Paul Sticht Center on Aging and Rehabilitation, Winston-Salem
Medizinische Hochschule Hannover, Hanover
Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux
Medical College of Wisconsin, Milwaukee
Deutsche Klinik fuer Diagnostik, Wiesbaden
Neurology Associates, P.C - Lincoln, Lincoln
Woodland Research Northwest, Rogers
Hopital Pierre Wertheimer - Hopital Neurologique, Paris
Texas Neurology, PA, Dallas
University of Colorado Anschutz Medical Campus, Aurora
St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center, Phoenix
Neuromuscular Research Center, Phoenix
Centre Hospitalier Esquirol, Limoges
UF Health Cancer Center, Gainesville
Emory University - School of Medicine, Atlanta
Heritage Medical Research Clinic - University Of Calgary, Calgary
University of Alberta - Walter C Mackenzie Health Sciences Centre (WCM), Edmonton
Montreal Neurological Institute and Hospital, Montreal
CHU-Nice - Hopital Pasteur 2, Nice
Aichi Medical University Hospital, Nagakute-shi
National Hospital Organization Chibahigashi National Hospital, Chiba
Murakami Karindoh Hospital, Fukuoka
Fukushima Medical University Hospital, Fukushima
National Hospital Organization Hokkaido Medical Center, Sapporo
National Hospital Organization Iou National Hospital, Kanazawa
Kagawa University Hospital, Kita-gun
Kitasato University Hospital, Sagamihara
Yokohama City University Hospital, Yokohama
National Hospital Organization Kumamoto Saishun Medical Center, Koshi-shi
Tohoku University Hospital, Sendai
Niigata University Medical And Dental Hospital, Niigata
Kansai Electric Power Hospital Recruiting, Fukushima-ku, Osaka-shi
National Hospital Organization Toneyama Medical Center, Toyonaka-shi
Shiga University of Medical Science Hospital, Ōtsu
National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka
Juntendo University Hospital, Bunkyo-ku
Tokyo Metropolitan Neurological Hospital, Fuchū
Toho University Omori Medical Center, Ōta-ku
Lead Sponsor
Mitsubishi Tanabe Pharma America Inc.
INDUSTRY